Africa

2 July 2024   List compiled by sister title features peer-reviewed IP lawyers from across six continents | 2024 edition “most comprehensive and rigorous” to date, says rankings editor | Data reveals gender ratio and practice area concentration by continent.

Latest Features

Africa
Government-led schemes to incentivise patents are leading to delays and prejudice against legitimate applicants. Tyron Grant of Spoor and Fisher explains how South Africa is tackling the problem.
Africa
The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy
Africa
Tedros Ghebreyesus was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.
Africa
A lack of blood donors and poor healthcare infrastructure inspired Temie Giwa-Tubosun to develop and deliver a life-saving app. LSIPR spoke to the founder of LifeBank.
Africa
Glenda Gray, CEO and president of the South African Medical Research Council, tells LSIPR of the life-saving work she is undertaking and her ambitious goals to improve the South African healthcare landscape.
Africa
There may be a path through the CRISPR patent jungle, but there are many obstacles still in the way, say European academics Timo Minssen, Esther van Zimmeren and Jakob Wested.
Africa
Politics has a huge impact on enforcement in Africa, Asia and the Middle East, a senior corporate counsel at Pfizer has told LSIPR in an interview.
Africa
Matshidiso Moeti was selected in the LSIPR 50 2017 publication for​ ​her influence on the life sciences industry. She featured in the government and policy​ ​section, as LSIPR reports.
All features


More News

9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.
24 March 2020   Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office.
21 March 2019   World Health Organization (WHO) experts have called for central registry on human genome editing research is needed, among a committee consensus that it would be irresponsible for any scientist to conduct gene-editing studies in people.
12 November 2018   Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products.
1 June 2018   Médecins Sans Frontières has welcomed the South African government’s release of a new IP policy, calling it an effort to take off a “patent blindfold”.
18 October 2017   CPA Global has found that Sanofi files the most patents covering human gene therapy and also spends the most on them overall.
3 October 2017   The World Intellectual Property Organization (WIPO) has partnered with trade group the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) to boost access to patent information.
More news